{
    "url_original": "https://www.wsj.com/articles/pfizer-biontech-expand-covid-19-vaccine-manufacturing-into-latin-america-11629974701?mod=business_lead_pos2",
    "url": "pfizer-biontech-expand-covid-19-vaccine-manufacturing-into-latin-america-11629974701",
    "title": "Pfizer, BioNTech Expand Covid-19 Vaccine Manufacturing Into Latin America",
    "sub_head": "Deal would allow Brazil’s Eurofarma to produce at least 100 million doses annually for distribution in the region",
    "category_1": "Business",
    "category_2": "Health Care",
    "time": "2021-08-26 06:45:00",
    "body": "Pfizer Inc.  and  BioNTech SE  said they are partnering with a Brazilian pharmaceutical company to help manufacture their Covid-19 vaccine in Latin America, which could help meet growing demand for the shot in the region.<br />Eurofarma will produce at least 100 million doses annually for distribution in the region, Pfizer and BioNTech said Thursday.<br />The doses will be in addition to those reaching Latin America through distribution channels such as Covax, the global initiative intended to get vaccines to low-income countries, and donations by the U.S., the companies said.<br />Financial terms of the deal weren’t disclosed.<br />Pfizer and BioNTech said manufacturing will begin next year, after the companies have completed a lengthy process known as technology transfer, in which they provide Eurofarma with top-secret information about the vaccine, manufacturing know-how and other key details."
}